These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

296 related items for PubMed ID: 3038500

  • 1. Sulbactam/ampicillin. A review of its antibacterial activity, pharmacokinetic properties, and therapeutic use.
    Campoli-Richards DM, Brogden RN.
    Drugs; 1987 Jun; 33(6):577-609. PubMed ID: 3038500
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Clinical efficacy and safety of sulbactam/ampicillin in patients suffering from chronic liver disease.
    Galante D, Esposito S, Barba D, Ruffilli MP.
    J Antimicrob Chemother; 1987 Apr; 19(4):527-32. PubMed ID: 3034850
    [Abstract] [Full Text] [Related]

  • 5. Sulbactam/ampicillin for treatment of polymicrobial pelvic infections.
    Hemsell DL.
    Drugs; 1986 Apr; 31 Suppl 2():22-5. PubMed ID: 3013569
    [Abstract] [Full Text] [Related]

  • 6. Worldwide clinical experience with sultamicillin.
    Pitts NE, Gilbert GS, Knirsch AK, Noguchi Y.
    APMIS Suppl; 1989 Apr; 5():23-34. PubMed ID: 2660868
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Antibacterial activity of ampicillin alone and in combination with sulbactam correlated with beta-lactamase production.
    Chao HP, Ho SW, Luh KT, Hsieh WC.
    Taiwan Yi Xue Hui Za Zhi; 1987 Mar; 86(3):241-7. PubMed ID: 3037003
    [No Abstract] [Full Text] [Related]

  • 10. Two regimens of sultamicillin in treating uncomplicated gonorrhoea.
    Farthing C, Thin RN, Smith S, Phillips I.
    Genitourin Med; 1985 Feb; 61(1):44-7. PubMed ID: 3002961
    [Abstract] [Full Text] [Related]

  • 11. Ampicillin-sulbactam: an update on the use of parenteral and oral forms in bacterial infections.
    Betrosian AP, Douzinas EE.
    Expert Opin Drug Metab Toxicol; 2009 Sep; 5(9):1099-112. PubMed ID: 19621991
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Sulbactam/ampicillin: in vitro spectrum, potency, and activity in models of acute infection.
    Retsema JA, English AR, Girard A, Lynch JE, Anderson M, Brennan L, Cimochowski C, Faiella J, Norcia W, Sawyer P.
    Rev Infect Dis; 1986 Sep; 8 Suppl 5():S528-34. PubMed ID: 3026001
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The parenteral kinetics of ampicillin/sulbactam in man.
    Foulds G, Knirsch AK, Stankewich JP, Weidler DR.
    Int J Clin Pharmacol Res; 1985 Sep; 5(2):79-86. PubMed ID: 2991150
    [Abstract] [Full Text] [Related]

  • 17. Beta-lactamase inhibitors from laboratory to clinic.
    Bush K.
    Clin Microbiol Rev; 1988 Jan; 1(1):109-23. PubMed ID: 3060240
    [Abstract] [Full Text] [Related]

  • 18. Ceftizoxime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
    Richards DM, Heel RC.
    Drugs; 1985 Apr; 29(4):281-329. PubMed ID: 3888599
    [Abstract] [Full Text] [Related]

  • 19. Use of ampicillin/sulbactam and sultamicillin in pediatric infections: a re-evaluation.
    Dajani A.
    J Int Med Res; 2001 Apr; 29(4):257-69. PubMed ID: 11675898
    [Abstract] [Full Text] [Related]

  • 20. Tazobactam-piperacillin compared with sulbactam-ampicillin, clavulanic acid-ticarcillin, sulbactam-cefoperazone, and piperacillin for activity against beta-lactamase-producing bacteria isolated from patients with complicated urinary tract infections.
    Nomura S, Hanaki H, Nagayama A.
    J Chemother; 1997 Apr; 9(2):89-94. PubMed ID: 9176745
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.